NicVAX (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "NicVAX" in English language version.

refsWebsite

Global rank English rank

7corporate-ir.net

3,174^th place

2,751^st place

5web.archive.org

1^st place

4nih.gov

4^th place

3doi.org

2^nd place

2semanticscholar.org

11^th place

8^th place

1drugabuse.gov

6,166^th place

5,476^th place

1nabitablet.com

low place

1uh.edu

3,907^th place

2,604^th place

1archive.today

14^th place

1medscape.com

719^th place

636^th place

1behavioralhealthcentral.com

low place

archive.today

Miranda Hitti (November 29, 2005). "Nicotine Vaccine Shows Early Promise". Medscape. Archived from the original on October 7, 2007. Retrieved 2006-09-19.

behavioralhealthcentral.com

"Price of Not Smoking - 0M; Nabi, GSK in NicVax Partnership | Latest News". Archived from the original on 2009-11-21. Retrieved 2009-11-28.

corporate-ir.net

phx.corporate-ir.net

"Nabi Biopharmaceuticals Announces Results of First NicVAX(R) Phase III Clinical Trial". 2016-01-17. Archived from the original on 2016-01-17. Retrieved 2023-10-01.
"Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial". 2019-03-05. Archived from the original on 2019-03-05. Retrieved 2023-10-01.
"Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months". Nabi Biopharmaceuticals. November 7, 2007.
"Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX". Nabi Biopharmaceuticals. May 2, 2007.
Thomas E. Rathjen (2006-10-12). "Nabi Biopharmaceuticals Completes Enrollment in NicVAX Phase IIB 'Proof-of-Concept' Clinical Trial". Nabi Biopharmeceuticals. Retrieved 2006-12-23.
"Nabi Biopharmaceuticals Initiates Pivotal Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence". Nabi Biopharmaceuticals. November 3, 2009.
"Nabi Biopharmaceuticals Initiates Second Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence". Nabi Biopharmaceuticals. March 17, 2010.

doi.org

Hatsukami, Dorothy K.; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR (2005). "Safety and immunogenicity of a nicotine conjugate vaccine in current smokers". Clinical Pharmacology & Therapeutics. 78 (5): 456–467. doi:10.1016/j.clpt.2005.08.007. PMID 16321612. S2CID 1218556.
Esterlis, Irina (22 February 2013). "Effect of a Nicotine Vaccine on Nicotine Binding to β₂*-Nicotinic Acetylcholine Receptors In Vivo in Human Tobacco Smokers". American Journal of Psychiatry. 170 (4): 399–407. doi:10.1176/appi.ajp.2012.12060793. PMC 3738000. PMID 23429725.
Maurer, P; Jennings GT; Willers J; Rohner F; Lindman Y; Roubicek K; Renner WA; Muller P; Bachmann MF (2005). "A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity". European Journal of Immunology. 35 (7): 2031–2040. doi:10.1002/eji.200526285. PMID 15971275. S2CID 44994620.

drugabuse.gov

Barbara Shine (October 2000). "Nicotine Vaccine Moves Toward Clinical Trials". National Institute on Drug Abuse. Archived from iuu the original on 2006-08-10. Retrieved 2006-09-19. {{cite web}}: Check |url= value (help)

medscape.com

Miranda Hitti (November 29, 2005). "Nicotine Vaccine Shows Early Promise". Medscape. Archived from the original on October 7, 2007. Retrieved 2006-09-19.

nabitablet.com

"nabi - Promoting And Inspiring Happiness". 2018-09-01. Archived from the original on 2018-09-01. Retrieved 2023-10-01.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hatsukami, Dorothy K.; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR (2005). "Safety and immunogenicity of a nicotine conjugate vaccine in current smokers". Clinical Pharmacology & Therapeutics. 78 (5): 456–467. doi:10.1016/j.clpt.2005.08.007. PMID 16321612. S2CID 1218556.
Esterlis, Irina (22 February 2013). "Effect of a Nicotine Vaccine on Nicotine Binding to β₂*-Nicotinic Acetylcholine Receptors In Vivo in Human Tobacco Smokers". American Journal of Psychiatry. 170 (4): 399–407. doi:10.1176/appi.ajp.2012.12060793. PMC 3738000. PMID 23429725.
Maurer, P; Jennings GT; Willers J; Rohner F; Lindman Y; Roubicek K; Renner WA; Muller P; Bachmann MF (2005). "A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity". European Journal of Immunology. 35 (7): 2031–2040. doi:10.1002/eji.200526285. PMID 15971275. S2CID 44994620.

ncbi.nlm.nih.gov

Esterlis, Irina (22 February 2013). "Effect of a Nicotine Vaccine on Nicotine Binding to β₂*-Nicotinic Acetylcholine Receptors In Vivo in Human Tobacco Smokers". American Journal of Psychiatry. 170 (4): 399–407. doi:10.1176/appi.ajp.2012.12060793. PMC 3738000. PMID 23429725.

semanticscholar.org

api.semanticscholar.org

Hatsukami, Dorothy K.; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR (2005). "Safety and immunogenicity of a nicotine conjugate vaccine in current smokers". Clinical Pharmacology & Therapeutics. 78 (5): 456–467. doi:10.1016/j.clpt.2005.08.007. PMID 16321612. S2CID 1218556.
Maurer, P; Jennings GT; Willers J; Rohner F; Lindman Y; Roubicek K; Renner WA; Muller P; Bachmann MF (2005). "A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity". European Journal of Immunology. 35 (7): 2031–2040. doi:10.1002/eji.200526285. PMID 15971275. S2CID 44994620.

uh.edu

law.uh.edu

Joseph Wang (August 17, 2000). "Is a Nicotine Vaccine the Magic Bullet for Smoking Cessation?". Health Law & Policy Institute, University of Houston. Retrieved 2006-09-19.

web.archive.org

Barbara Shine (October 2000). "Nicotine Vaccine Moves Toward Clinical Trials". National Institute on Drug Abuse. Archived from iuu the original on 2006-08-10. Retrieved 2006-09-19. {{cite web}}: Check |url= value (help)
"nabi - Promoting And Inspiring Happiness". 2018-09-01. Archived from the original on 2018-09-01. Retrieved 2023-10-01.
"Nabi Biopharmaceuticals Announces Results of First NicVAX(R) Phase III Clinical Trial". 2016-01-17. Archived from the original on 2016-01-17. Retrieved 2023-10-01.
"Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial". 2019-03-05. Archived from the original on 2019-03-05. Retrieved 2023-10-01.
"Price of Not Smoking - 0M; Nabi, GSK in NicVax Partnership | Latest News". Archived from the original on 2009-11-21. Retrieved 2009-11-28.